samedan logo
 
 
spacer
home > ict > autumn 2017 > fastening pharmaceuticals
PUBLICATIONS
International Clinical Trials

Fastening Pharmaceuticals

As consumers increasingly embrace the more affordable nature of wearable devices choosing to monitor their own health and wellbeing with gadgets such as FitBit or Jawbone it is no surprise that the wearable device market is set to grow to 25 billion by 2019 (1). However, this wearable technology has also been widely adopted by other markets, and none more so than by the healthcare industry, which reportedly earned revenues of $5.1 billion in 2015, according to a recent report by Frost and Sullivan (2). This wearable devices market is set to continue to revolutionise the healthcare industry with estimates that it will reach over $18 billion by 2020 (3).

It has been widely reported that CROs can leverage this wearable device trend to enable easier remote patient monitoring, improved therapeutic outcomes and deeper insight into clinical studies. Alongside this, traditional outsourcing in the area of clinical trial data management is seeing notable increases in market concentration, while speciality service providers are experiencing unprecedented growth. The Tufts Center for the Study of Drug Development estimates that, since 2011, small niche or speciality service providers have enjoyed strong relative annual growth, approaching 10% (4).

However, the clinical trial process is known to be complex, painstaking and is often criticised for not being sufficiently patient-centric. Therefore, it makes sense to innovate in this area to ease the challenges, streamline the various activities and generate better patient engagement. One way to do this is via digital technology and mobile health (5).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jeremy Wheeler, Head of Statistics at Quanticate, is an experienced statistician with over 25 years' experience, including over 10 years in the pharma industry. He has worked in all phases of drug development, with particular knowledge of clinical studies, early phase design and analysis, methodology/biomarker studies and pharmacogenomics. Jeremy has a strong background in epidemiology and observational studies. He has applied this knowledge to post-marketing studies, meta-analyses and clinical registry studies.
spacer
Jeremy Wheeler
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

York Health Economics Consortium offers an updated training event

Health economics evidence is a key element in much health services research and particularly in health technology assessments, including submissions for NICE single technology appraisals. Identifying economic evidence to inform submissions involves searches in a range of databases and uses a variety of strategies.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

PHARM Connect Congress 2018

13-14 March 2018, Corinthia Hotel Budapest, Hungary

PHARM Connect Congress is the premier networking business event dedicated to pharmaceutical and biotechnology innovations and trends from development through commercialization in Central and Eastern Europe and the CIS region. The two days event offers the perfect setting for solution providers to present their products and services directly to key decision makers playing a key role in the pharmaceutical industry in Central Eastern Europe.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement